Zai Lab Announces First Quarter 2022 Financial Results and

Company to Host Conference Call and Webcast on May 11, 2022, at 8:00 a.m. ET...

Related Keywords

China ,Shanghai ,United States ,Cambridge ,Cambridgeshire ,United Kingdom ,Lisbon ,Lisboa ,Portugal ,American ,David Tran ,Optune Lua ,Josh Smiley ,Eli Lilly ,Seek National Reimbursement Drug List ,Amgen ,Global Business Services ,American Society Of Clinical Oncology ,Submit Zai Lab ,Zai Lab ,University Of Florida ,Zai Lab Limited ,Audit Committee ,Nasdaq ,Mcknight Brain Institute ,Co Lilly ,European Union ,Public Company Accounting Oversight Board ,Society Of Gynecologic Oncology ,Division Of Neuro ,Blueprint Medicines Corporation ,European Congress ,Mirati Therapeutics Inc ,American Depositary Shares Adss Of The Company ,Point Therapeutics Inc ,Exchange Commission ,American Association For Cancer Research ,National Medical Products Administration ,Holding Foreign Companies Accountable ,Board Of Directors The Company ,Lab Limited ,Chief Executive Officer ,Greater China ,Product Highlights ,Gynecologic Oncology ,Tumor Treating ,Treating Fields ,Mirati Therapeutics ,Clinical Oncology ,Fast Track ,Biologics License Application ,Turning Point Therapeutics ,Turning Point ,Blinded Independent Central Review ,Cullinan Oncology ,Cancer Research ,Blueprint Medicines ,Global Rights ,National Reimbursement Drug List ,Asia Pacific Rights ,Entasis Therapeutics ,Clinical Microbiology ,Infectious Diseases ,Annual Conference ,Holding Foreign Companies Accountable Act ,American Depositary Shares ,Chief Operating Officer ,Nasdaq Zlab ,